よむ、つかう、まなぶ。
【参考資料３】【英版R4.1.17】Nippon AMR One Health Report (NAOR) 2020 (76 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_23261.html |
| 出典情報 | 国際的に脅威となる感染症対策関係閣僚会議 薬剤耐性ワンヘルス動向調査検討会（第9回 1／17）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
Table 86 Outcomes of Interest Before and After the Timing of Primary Care Physician Registrations and the
Within-Group and Between-Group Differences (Difference-in-Differences [DID] estimate) in the Unadjusted and
Adjusted Analyses
Test Cohort
(N=41,362)
Difference-in-differences estimate
exponential coefficients for the interaction
term in the model
Control Cohort
(N=1,344,951)
Incidence rate
ratio (95%
confidence
interval)
Crude estimation
index
Adjusted estimation
index
17,687,323 (1461)
0.79 (0.79-0.80)
1.08 (1.07-1.09)
1.08 (1.07-1.09)
2,225,802 (138)
1,209,453 (100)
0.73 (0.72-0.73)
0.89 (0.87-0.90)
0.89 (0.87-0.90)
0.89 (0.88-0.89)
31,225,108 (1935)
19,285,233 (1593)
0.82 (0.82-0.82)
1.09 (1.08-1.11)
1.11 (1.09-1.12)
100,878 (271)
0.95 (0.94-0.96)
4,067,555 (252)
2,474,883 (204)
0.80 (0.80-0.82)
1.17 (1.14-1.20)
1.19 (1.15-1.23)
305 (0.8)
0.40 (0.40-0.52)
36,846 (2.2)
12,194 (1.1)
0.44 (0.43-0.45)
1.08 (0.93-1.25)
1.07 (0.92-1.25)
Before (incidence
rate per 1000
person-months)
After (incidence
rate per 1000
person-months)
Person-months
496,344
372,258
Total visits
1,060,700 (2137)
657,544 (1766)
Out-of-hour
visits
92,482 (186)
Total DOTs
Incidence rate
ratio (95%
confidence
interval)
Before (incidence
rate per 1000
person-months)
After (incidence rate
per 1000 personmonths)
16,139,412
12,104,559
0.83 (0.82-0.83)
29,627,081 (1836)
44,736 (120)
0.64 (0.63-0.65)
1,090,213 (2196)
728,279 (1956)
DOTs of
extremely
broad-spectrum
antibiotics
141,310 (285)
Admissions
892 (1.8)
75
Within-Group and Between-Group Differences (Difference-in-Differences [DID] estimate) in the Unadjusted and
Adjusted Analyses
Test Cohort
(N=41,362)
Difference-in-differences estimate
exponential coefficients for the interaction
term in the model
Control Cohort
(N=1,344,951)
Incidence rate
ratio (95%
confidence
interval)
Crude estimation
index
Adjusted estimation
index
17,687,323 (1461)
0.79 (0.79-0.80)
1.08 (1.07-1.09)
1.08 (1.07-1.09)
2,225,802 (138)
1,209,453 (100)
0.73 (0.72-0.73)
0.89 (0.87-0.90)
0.89 (0.87-0.90)
0.89 (0.88-0.89)
31,225,108 (1935)
19,285,233 (1593)
0.82 (0.82-0.82)
1.09 (1.08-1.11)
1.11 (1.09-1.12)
100,878 (271)
0.95 (0.94-0.96)
4,067,555 (252)
2,474,883 (204)
0.80 (0.80-0.82)
1.17 (1.14-1.20)
1.19 (1.15-1.23)
305 (0.8)
0.40 (0.40-0.52)
36,846 (2.2)
12,194 (1.1)
0.44 (0.43-0.45)
1.08 (0.93-1.25)
1.07 (0.92-1.25)
Before (incidence
rate per 1000
person-months)
After (incidence
rate per 1000
person-months)
Person-months
496,344
372,258
Total visits
1,060,700 (2137)
657,544 (1766)
Out-of-hour
visits
92,482 (186)
Total DOTs
Incidence rate
ratio (95%
confidence
interval)
Before (incidence
rate per 1000
person-months)
After (incidence rate
per 1000 personmonths)
16,139,412
12,104,559
0.83 (0.82-0.83)
29,627,081 (1836)
44,736 (120)
0.64 (0.63-0.65)
1,090,213 (2196)
728,279 (1956)
DOTs of
extremely
broad-spectrum
antibiotics
141,310 (285)
Admissions
892 (1.8)
75